These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 11794455)

  • 21. Preventing and alleviating patients' symptoms of nausea and vomiting while in the care of the ambulance service - a qualitative study.
    Westerlund A; Vicente V; Hjelte Judell O; Lindström V
    Int Emerg Nurs; 2016 Sep; 28():34-8. PubMed ID: 27068749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of motion sickness in prehospital trauma care.
    Fleischhackl R; Dörner C; Scheck T; Fleischhackl S; Hafez J; Kober A; Bertalanffy P; Hoerauf K
    Anaesthesia; 2003 Apr; 58(4):373-7. PubMed ID: 12688274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palonosetron versus other 5-HT₃ receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States.
    Craver C; Gayle J; Balu S; Buchner D
    J Med Econ; 2011; 14(3):341-9. PubMed ID: 21542674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
    Herrstedt J; Apornwirat W; Shaharyar A; Aziz Z; Roila F; Van Belle S; Russo MW; Levin J; Ranganathan S; Guckert M; Grunberg SM
    J Clin Oncol; 2009 Nov; 27(32):5363-9. PubMed ID: 19805683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ondansetron is safe and effective for prehospital treatment of nausea and vomiting by paramedics.
    Salvucci AA; Squire B; Burdick M; Luoto M; Brazzel D; Vaezazizi R
    Prehosp Emerg Care; 2011; 15(1):34-8. PubMed ID: 21091329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy.
    Arpornwirat W; Albert I; Hansen VL; Levin J; Bandekar RR; Grunberg SM
    Cancer; 2009 Dec; 115(24):5807-16. PubMed ID: 19834961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of preoperative dexamethasone on early oral intake, vomiting and pain after tonsillectomy.
    Kaan MN; Odabasi O; Gezer E; Daldal A
    Int J Pediatr Otorhinolaryngol; 2006 Jan; 70(1):73-9. PubMed ID: 15979735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nausea prophylaxis using transdermal scopolamine in the setting of patient-controlled analgesia.
    Harris SN; Sevarino FB; Sinatra RS; Preble L; O'Connor TZ; Silverman DG
    Obstet Gynecol; 1991 Oct; 78(4):673-7. PubMed ID: 1923171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Korean hand acupressure for motion sickness in prehospital trauma care: a prospective, randomized, double-blinded trial in a geriatric population.
    Bertalanffy P; Hoerauf K; Fleischhackl R; Strasser H; Wicke F; Greher M; Gustorff B; Kober A
    Anesth Analg; 2004 Jan; 98(1):220-223. PubMed ID: 14693623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of trauma cases in different types of mass gathering events.
    Koçak H; Tuncay İ
    Ulus Travma Acil Cerrahi Derg; 2022 Jun; 28(6):781-789. PubMed ID: 35652867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conflagration in an ambulance oxygen system.
    Benson DM; Wecht CH
    J Trauma; 1975 Jun; 15(6):536-40. PubMed ID: 1127787
    [No Abstract]   [Full Text] [Related]  

  • 33. Supplemental oxygen reduces serotonin levels in plasma and platelets during colorectal surgery and reduces postoperative nausea and vomiting: Retraction.
    Eur J Anaesthesiol; 2012 Mar; 29(3):164. PubMed ID: 22317774
    [No Abstract]   [Full Text] [Related]  

  • 34. Perioperative oxygenation-what's the stress?
    Larvin J; Edwards M; Martin DS; Feelisch M; Grocott MPW; Cumpstey AF
    BJA Open; 2024 Jun; 10():100277. PubMed ID: 38545565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caring science research in the ambulance services: an integrative systematic review.
    Wireklint Sundström B; Bremer A; Lindström V; Vicente V
    Scand J Caring Sci; 2019 Mar; 33(1):3-33. PubMed ID: 30252151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supplemental oxygen does not reduce postoperative nausea and vomiting after thyroidectomy.
    Joris JL; Poth NJ; Djamadar AM; Sessler DI; Hamoir EE; Defêchereux TR; Meurisse MR; Lamy ML
    Br J Anaesth; 2003 Dec; 91(6):857-61. PubMed ID: 14633758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of oxygen for reducing nausea and vomiting during emergency transport of patients older than 60 years with minor trauma.
    Kober A; Fleischackl R; Scheck T; Lieba F; Strasser H; Friedmann A; Sessler DI
    Mayo Clin Proc; 2002 Jan; 77(1):35-8. PubMed ID: 11794455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative oxygen administration does not reduce the incidence or severity of nausea or vomiting associated with neuraxial anesthesia for cesarean delivery.
    Phillips TW; Broussard DM; Sumrall WD; Hart SR
    Anesth Analg; 2007 Oct; 105(4):1113-7, table of contents. PubMed ID: 17898396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the efficacy of supplemental oxygen for the prevention of postoperative nausea and vomiting depend on the measured outcome, observational period or site of surgery?
    Turan A; Apfel CC; Kumpch M; Danzeisen O; Eberhart LH; Forst H; Heringhaus C; Isselhorst C; Trenkler S; Trick M; Vedder I; Kerger H
    Anaesthesia; 2006 Jul; 61(7):628-33. PubMed ID: 16792606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
    Chawla SP; Grunberg SM; Gralla RJ; Hesketh PJ; Rittenberg C; Elmer ME; Schmidt C; Taylor A; Carides AD; Evans JK; Horgan KJ
    Cancer; 2003 May; 97(9):2290-300. PubMed ID: 12712486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.